First Time Loading...

Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 7.6 USD -0.78% Market Closed
Updated: May 23, 2024

Net Margin
Burning Rock Biotech Ltd

-121.6%
Current
-145%
Average
-8.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-121.6%
=
Net Income
-653.7m
/
Revenue
537.4m

Net Margin Across Competitors

Country CN
Market Cap 82.1m USD
Net Margin
-122%
Country US
Market Cap 283.5B USD
Net Margin
11%
Country US
Market Cap 167.7B USD
Net Margin
13%
Country US
Market Cap 115.7B USD
Net Margin
39%
Country US
Market Cap 108.7B USD
Net Margin
29%
Country AU
Market Cap 134.3B AUD
Net Margin
17%
Country US
Market Cap 84.2B USD
Net Margin
2%
Country US
Market Cap 60.9B USD
Net Margin
-116%
Country US
Market Cap 43.1B USD
Net Margin
-33%
Country US
Market Cap 33B USD
Net Margin
12%
Country KR
Market Cap 38.3T KRW
Net Margin
25%

Profitability Report

View the profitability report to see the full profitability analysis for Burning Rock Biotech Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-121.6%
=
Net Income
-653.7m
/
Revenue
537.4m
What is the Net Margin of Burning Rock Biotech Ltd?

Based on Burning Rock Biotech Ltd's most recent financial statements, the company has Net Margin of -121.6%.